NASDAQ:NTRB Nutriband (NTRB) Stock Price, News & Analysis → Reclusive millionaire’s final warning about America (From Weiss Ratings) (Ad) Free NTRB Stock Alerts $5.19 -0.28 (-5.12%) (As of 04:27 PM ET) Add Compare Share Share Today's Range$5.11▼$5.4850-Day Range$3.35▼$6.1652-Week Range$1.53▼$6.75Volume33,671 shsAverage Volume36,673 shsMarket Capitalization$57.30 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Get Nutriband alerts: Email Address Ad Weiss RatingsReclusive millionaire’s final warning about AmericaThis crisis that's likly to begin in this country — before the election — could be bigger and more destructive than any crisis I've ever seen. That's why, no matter what you do, make sure you watch my short video and learn the three steps you need to take right now.Click here to learn how to prepare before it's too late. About Nutriband Stock (NASDAQ:NTRB)Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida.Read More NTRB Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NTRB Stock News HeadlinesMay 26, 2024 | finance.yahoo.comNutriband Inc. (NTRB)May 23, 2024 | theglobeandmail.comNutriband (NASDAQ: NTRB) Schedules Live Investor Webinar, Q&A SessionJune 18, 2024 | Weiss Ratings (Ad)Reclusive millionaire’s final warning about AmericaThis crisis that's likly to begin in this country — before the election — could be bigger and more destructive than any crisis I've ever seen. That's why, no matter what you do, make sure you watch my short video and learn the three steps you need to take right now.May 21, 2024 | finance.yahoo.comJoin Nutriband's Exclusive Live Investor Webinar and Q&A Session on May 30May 16, 2024 | finanznachrichten.deNutriband Inc.: Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of DirectorsMay 8, 2024 | theglobeandmail.comNutriband’s (NASDAQ: NTRB) Transdermal Patch with Abuse-Deterrent Tech Funded to Seek FDA ApprovalApril 25, 2024 | finance.yahoo.comIBN Coverage Initiated for Nutriband Inc.April 24, 2024 | finanznachrichten.deNutriband Inc.: Nutriband Closes $8.4M Private Placement for Commercial Development of Aversa Fentanyl Transdermal Patch Through FDA SubmissionJune 18, 2024 | Porter & Company (Ad)Kiss of death from Joe BidenBiden cannot lose this election. A bombshell new documentary exposes how the D.C establishment has engineered an “electoral failsafe” that all but guarantees Democratic victory… not just in 2024 but every future election.April 24, 2024 | finance.yahoo.comNutriband Closes $8.4M Private Placement for Commercial Development of Aversa(R) Fentanyl Transdermal Patch Through FDA SubmissionApril 21, 2024 | uk.investing.comNutriband closes funding for abuse-deterrent fentanyl patchApril 1, 2024 | finance.yahoo.comNutriband Inc. Begins Manufacturing for Major Sports Brand Licensee Fit for Life Group, Whose Collection of Partnered Brands Include Reebok, Adidas and New BalanceMarch 28, 2024 | marketwatch.comNutriband Shares Rise 30% After Fentanyl Patch Partnership News, Planned FDA SubmissionMarch 27, 2024 | benzinga.comGerald Goodman's Net WorthMarch 27, 2024 | finanznachrichten.deNutriband Inc.: Nutriband Provides Clinical and Regulatory Path Overview for Lead Product - AVERSA Fentanyl Transdermal PatchMarch 27, 2024 | finance.yahoo.comNutriband Provides Clinical and Regulatory Path Overview for Lead Product - AVERSA(R) Fentanyl Transdermal PatchJanuary 29, 2024 | finance.yahoo.comNutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1stJanuary 26, 2024 | finanznachrichten.deNutriband Inc.: Nutriband CEO Publishes Letter to ShareholdersJanuary 26, 2024 | finance.yahoo.comNutriband CEO Publishes Letter to ShareholdersJanuary 5, 2024 | finance.yahoo.comNutriband Signs Commercial Development and Clinical Supply Agreement With Kindeva Drug Delivery for Aversa(TM) Fentanyl, an Abuse Deterrent Fentanyl PatchDecember 29, 2023 | morningstar.comNutriband Inc NTRBDecember 18, 2023 | investorplace.comNTRB Stock Earnings: Nutriband Reported Results for Q3 2023November 28, 2023 | finance.yahoo.comNutriband Inc. Expands its AI Kinesiology Tape Portfolio with the Launch of AI Tape Heating and CoolingNovember 28, 2023 | finance.yahoo.comNutriband Inc. Expands its AI Kinesiology Tape Portfolio with the Launch of AI Tape Heating and CoolingOctober 11, 2023 | finance.yahoo.comNutriband’s Aversa(TM) Buprenoprhine May Reach Peak Annual Sales of $70-130 Million Based on Market Assessment by Leading Healthcare Consulting FirmSeptember 20, 2023 | finanznachrichten.deFinancialnewsmedia.com: Demand for Abuse Deterrent Formulation Technology Skyrocketing as Opiate Abuse is on the RiseSeptember 20, 2023 | finanznachrichten.deNutriband Inc.: Nutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent TechnologySee More Headlines Receive NTRB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nutriband and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/31/2024Today6/18/2024Next Earnings (Estimated)9/09/2024Fiscal Year End1/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryN/A Current SymbolNASDAQ:NTRB CUSIPN/A CIK1676047 Webnutriband.com Phone(407) 377-6695FaxN/AEmployees3Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.77) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-5,490,000.00 Net Margins-315.56% Pretax Margin-315.56% Return on Equity-71.77% Return on Assets-56.63% Debt Debt-to-Equity Ratio0.03 Current Ratio6.16 Quick Ratio6.04 Sales & Book Value Annual Sales$2.09 million Price / Sales28.89 Cash FlowN/A Price / Cash FlowN/A Book Value$0.73 per share Price / Book7.49Miscellaneous Outstanding Shares11,040,000Free Float6,274,000Market Cap$60.39 million OptionableNot Optionable Beta1.13 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Serguei Melnik (Age 50)Founder, President, Company Secretary & Executive Chairman of the Board Comp: $175kMr. Gareth Sheridan (Age 34)Founder, CEO & Director Comp: $175kMr. Gerald Goodman (Age 76)CFO & Chief Accounting Officer Comp: $140kDr. Alan Smith Ph.D. (Age 58)COO & President of 4P Therapeutics Comp: $159kDr. Jeffrey Patrick Pharm.D. (Age 54)Chief Scientific Officer Mr. Michael Myer (Age 39)President of Pocono Pharmaceutical Comp: $40.6kMr. Tyler Overk (Age 40)Head of Active Intelligence More ExecutivesKey CompetitorsReWalk RoboticsNASDAQ:RWLKLipocineNASDAQ:LPCNEyenoviaNASDAQ:EYENConformisNASDAQ:CFMSscPharmaceuticalsNASDAQ:SCPHView All CompetitorsInstitutional OwnershipVirtu Financial LLCBought 12,862 shares on 5/20/2024Ownership: 0.117%View All Institutional Transactions NTRB Stock Analysis - Frequently Asked Questions How have NTRB shares performed in 2024? Nutriband's stock was trading at $2.32 at the beginning of 2024. Since then, NTRB stock has increased by 133.2% and is now trading at $5.41. View the best growth stocks for 2024 here. Are investors shorting Nutriband? Nutriband saw a increase in short interest in the month of May. As of May 31st, there was short interest totaling 65,700 shares, an increase of 279.8% from the May 15th total of 17,300 shares. Based on an average daily volume of 58,400 shares, the short-interest ratio is currently 1.1 days. Currently, 2.0% of the company's stock are sold short. View Nutriband's Short Interest. When is Nutriband's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, September 9th 2024. View our NTRB earnings forecast. How were Nutriband's earnings last quarter? Nutriband Inc. (NASDAQ:NTRB) issued its quarterly earnings data on Friday, May, 31st. The company reported ($0.21) EPS for the quarter. The company had revenue of $0.41 million for the quarter. Nutriband had a negative trailing twelve-month return on equity of 71.77% and a negative net margin of 315.56%. When did Nutriband's stock split? Nutriband shares split on the morning of Monday, August 15th 2022. The 13-6 split was announced on Monday, August 15th 2022. The newly issued shares were payable to shareholders after the closing bell on Monday, August 15th 2022. An investor that had 100 shares of stock prior to the split would have 217 shares after the split. Who are Nutriband's major shareholders? Nutriband's stock is owned by many different retail and institutional investors. Top institutional shareholders include Virtu Financial LLC (0.12%). How do I buy shares of Nutriband? Shares of NTRB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:NTRB) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | Sponsoredwhy 99.94% won’t make you moneyI believe there's only 5-7 stocks that you should trade in 2024. But here's the catch…because there's alway...Prosper Trading Academy | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredExecutive Order To Wipe Out Your Bank AccountsDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nutriband Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nutriband With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
